|
KMID : 0614620210780020117
|
|
Korean Journal of Gastroenterology
2021 Volume.78 No. 2 p.117 ~ p.128
|
|
|
SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID
|
|
Lee Yoo-Jin
Kim Seong-Eun
Park Yong-Eun
Chang Ji-Young
Song Hyun-Joo
Kim Duck-Hwan
Yang Young-Joo
Kim Byung-Chang
Lee Jae-Gon
Yang Hee-Chan
Choi Mi-Young
Myung Seung-Jae
|
|
|
Abstract
|
|
|
|
Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus, is threatening global health worldwide with unprecedented contagiousness and severity. The best strategy to overcome COVID-19 is a vaccine. Various vaccines are currently being developed, and mass vaccination is in progress. Despite the very encouraging clinical trial results of these vaccines, there is insufficient information on the safety and efficacy of vaccines for inflammatory bowel disease (IBD) patients facing various issues. After reviewing current evidence and international guidelines, the Korean Association for the Study of Intestinal Diseases (KASID) developed an expert consensus statement on COVID-19 vaccination issues for Korean IBD patients. This expert consensus statement emphasizes that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination be strongly recommended for IBD patients, and it is safe for IBD patients receiving immunomodulatory therapy.
|
|
|
KEYWORD
|
|
|
COVID-19 vaccines, SARS-CoV-2, COVID-19, Inflammatory bowel diseases
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|